Evidence map›Paper›PMID 28185196›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2017

Dual Detection of Nucleolytic and Proteolytic Markers of Lysosomal Cell Death: DNase II-Type Breaks and Cathepsin D.

Candace L Minchew, Vladimir V Didenko

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Candace L MinchewBaylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, 77030, USA.
Vladimir V DidenkoBaylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, 77030, USA. vdidenko@bcm.edu.
Baylor College of Medicine · US

Funding

FRET probes for analysis of serpin-mediated apoptosis in focal brain ischemiaR01NS082553 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2014 to 2016
$946k
APMV-topoisomerase assay for comprehensive assessment of efferocytosis in tissueR21AR066931 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2014 to 2015
$366k
Apoptosis driven by elastase inhibitor: new approach to detection and study.R21CA178365 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2013 to 2014
$357k
NCI NIH HHS R21 CA178365NIAMS NIH HHS R21 AR066931NINDS NIH HHS R01 NS082553
6 · The paper itself

Abstract

Lysosomes contain hydrolytic enzymes that can degrade proteins and DNA. Leakage of these reactive compounds through a compromised lysosomal membrane causes lysosomal cell death, which can have apoptotic, necrotic, or mixed morphology. Lysosomal cathepsin proteases, such as cathepsin D, and the lysosomal endonuclease, DNase II, have both been implicated in lysosome-related cell death. Here, we present a fluorescence dual-labeling technique for simultaneous visualization of these two markers of lysosomal activity linked to cell death. The approach labels the intracellular distribution of cathepsin D and the sites with DNase II-type breaks in fixed tissue sections. It determines the lysosomal or extra-lysosomal localization of the markers and can be useful in studying pathways and signals of lysosomal cell death.

Indexed as

BiomarkersCell DeathApoptosisBiological AssayCathepsin DDNA BreaksEndodeoxyribonucleasesLysosomesPhagosomesProteolysisBiomarkersCathepsin Ddeoxyribonuclease IIEndodeoxyribonucleasesCathepsin DClearance of apoptotic cellsDNA breaksDNase IIDNase II-type breaksFlorescence dual-labeling techniqueLysosomal cell deathLysosomesPhagolysosomesVaccinia topoisomerase-based labeling

Identifiers

PMID28185196
PMCPMC5654642
OpenAlexW2586891582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.